Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 501

1.
2.

Treatment of hepatitis C in HIV-coinfected patients.

Hughes CA, Shafran SD.

Ann Pharmacother. 2006 Mar;40(3):479-89; quiz 582-3. Epub 2006 Feb 28. Review.

PMID:
16507622
4.

Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.

Bräu N.

J Antimicrob Chemother. 2005 Dec;56(6):991-5. Epub 2005 Nov 24.

5.

HIV and hepatitis C coinfection.

Matthews GV, Dore GJ.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. Review.

PMID:
18707597
6.

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.

Zylberberg H, Benhamou Y, Lagneaux JL, Landau A, Chaix ML, Fontaine H, Bochet M, Poynard T, Katlama C, Pialoux G, Bréchot C, Pol S.

Gut. 2000 Nov;47(5):694-7.

7.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
8.

Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.

Yu JW, Sun LJ, Zhao YH, Kang P, Gao J, Li SC.

Liver Int. 2009 Nov;29(10):1485-93. doi: 10.1111/j.1478-3231.2009.02080.x. Epub 2009 Jul 7.

PMID:
19602134
9.

Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.

Kumar R, Singla V, Kacharya Sk.

Trop Gastroenterol. 2008 Jul-Sep;29(3):136-47. Review.

PMID:
19115605
10.

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.

Pineda JA, Mira JA, Gil Ide L, Valera-Bestard B, Rivero A, Merino D, Girón-González JA, Ríos-Villegas MJ, González-Serrano M, Collado A, García-García JA, Carrillo-Gómez R, López-Cortés LF, Gómez-Mateos J.

J Antimicrob Chemother. 2007 Dec;60(6):1347-54. Epub 2007 Oct 14.

11.

Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office.

Tien PC; Veterans Affairs Hepatitis C Resource Center Program; National Hepatitis C Program Office.

Am J Gastroenterol. 2005 Oct;100(10):2338-54. Erratum in: Am J Gastroenterol. 2005 Nov;100(11):2609.

PMID:
16181388
12.
13.
14.

Management of hepatitis C in HIV infected and other immunocompromised individuals.

Seth AK.

Trop Gastroenterol. 2006 Jul-Sep;27(3):111-7. Review.

PMID:
17310553
15.

A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.

Murata M, Furusyo N, Ogawa E, Mitsumoto F, Hiramine S, Ikezaki H, Takayama K, Shimizu M, Toyoda K, Kainuma M, Hayashi J.

J Infect Chemother. 2014 May;20(5):320-4. doi: 10.1016/j.jiac.2013.11.006. Epub 2014 Jan 27.

PMID:
24477330
16.
17.

Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.

Righi E, Beltrame A, Bassetti M, Lindstrom V, Mazzarello G, Dentone C, Di Biagio A, Ratto S, Viscoli C.

Infection. 2008 Aug;36(4):358-61. doi: 10.1007/s15010-008-7319-5. Epub 2008 Jul 19.

PMID:
18642111
18.

Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals.

Hopkins S, Lambourne J, Farrell G, McCullagh L, Hennessy M, Clarke S, Mulcahy F, Bergin C.

HIV Med. 2006 May;7(4):248-54.

19.

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

Mira JA, Gutiérrez-Valencia A, Gil Ide L, Merino D, Rivero A, Ríos-Villegas MJ, Delgado M, González-Serrano M, Collado A, Torres-Tortosa M, Omar M, López-Ruz MA, Macías J, Arponen S, Pineda JA.

Clin Infect Dis. 2009 Oct 15;49(8):e84-91. doi: 10.1086/605677.

20.

Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

Schulze Zur Wiesch J, Pieper D, Stahmer I, Eiermann T, Buggisch P, Lohse A, Hauber J, van Lunzen J.

Clin Infect Dis. 2009 Aug 1;49(3):466-72. doi: 10.1086/600399.

Items per page

Supplemental Content

Write to the Help Desk